Siplizumab (Anti-CD2), 1mg*25

Siplizumab (Anti-CD2), 1mg*25

Tafasitamab (Anti-CD19), 1mg*5

Tafasitamab (Anti-CD19), 1mg*5

Tafasitamab (Anti-CD19), 1mg

2.143,19 RON
SKU
SKM_A2563_1mg

Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.

Mai multe informatii
Price 1.801,00 RON (preturile sunt fara TVA)
Description

Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.